BST Global recently launched a range of advanced injectable treatments from Hyamed Laboratories, bringing Swiss-patented biostimulators and fillers to the South African aesthetic medicine market. The event took place at Palazzo Montecasino on 3 October 2024, marking an expansion in available treatment options for local practitioners and patients seeking sophisticated, scientifically developed solutions.
This product line introduces South Africa to patented cross-linking technology designed to improve treatment longevity and reduce potential adverse effects. Developed by Hyamed Laboratories, each product has undergone comprehensive testing to support both efficacy and safety, underscoring BST Global’s commitment to high standards in aesthetic medicine.
Bringing Swiss Precision to Local Aesthetic Practices
The recent launch highlights Hyamed Laboratories’ innovative approach, focusing on reducing BDDE levels in cross-linked products for better patient tolerance and satisfaction. High G-Prime technology ensures each product delivers durable results, which is particularly beneficial for practitioners looking to provide effective, long-lasting treatments tailored to individual needs.
Enhancing Access to Advanced Aesthetic Options
“We are pleased to see the positive reception from the aesthetic community in Sub-Saharan Africa,” stated Suné Theisinger, CEO of BST Global. “These products offer a blend of high-quality ingredients and advanced formulations. Our goal is to make them accessible and beneficial for the growing demand for advanced aesthetic treatments in the region.”
As a female-led company, BST Global emphasizes inclusivity and innovation in its approach. Theisinger added, “Our leadership team’s varied experiences help us to bring a fresh perspective to the field, focusing on service quality alongside product reliability.”
Industry Experts Share Insights on the Latest Advancements
At the launch event, practitioners had the opportunity to hear from respected professionals in the field. Dr Chris Giezing discussed achieving natural-looking outcomes with injectables, while Dr Juanri Jonck, medical advisor for BST Global, presented contemporary anti-ageing protocols for 2024. These discussions provided practitioners with practical insights into applying the new range to meet diverse patient needs.
BST Global’s new portfolio underscores its position in the local aesthetic industry as a trusted distributor of internationally developed technologies. The company’s exclusive partnership with Hyamed Laboratories brings an added layer of assurance, ensuring South African practitioners have access to cutting-edge solutions supported by scientific research.
For more information about the Hyamed Laboratories range distributed in South Africa by BST Global, please visit www.bstglobal.co.za
About BST Global
Established in 2023, BST Global is focused on distributing innovative aesthetic products in Sub-Saharan Africa. The company’s exclusive agreements with international manufacturers allow it to offer a range of high-quality injectable solutions that cater to the specific needs of both practitioners and patients.
BST Global’s portfolio includes a wide range of solutions, from injectable facial implants to biotstimulators, skin boosters and biorevitalizers.
Rochelle is the founder and driving force behind Aesthetic Appointment. With a passion for the aesthetics and pro-ageing industry in South Africa, she has been in the aesthetic publishing industry since 2012, dedicated to creating a valuable platform for insights and knowledge, bridging the gap between patients and doctors - delivering reliable, medical-based information. Rochelle firmly believes in the power of a good skincare regimen, especially when started at home, and is committed to educating consumers about the myriad of treatments, procedures, and products available to them.